Cargando…
Long noncoding RNA MALAT1 as a candidate serological biomarker for the diagnosis of non‐small cell lung cancer: A meta‐analysis
BACKGROUND: To investigate the diagnostic efficacy of long noncoding RNA metastasis‐associated in lung adenocarcinoma transcript l (MALAT1) as a candidate serological biomarker for non‐small cell lung cancer (NSCLC). METHODS: Diagnostic studies relevant to circulation long noncoding RNA MALAT1 as a...
Autores principales: | Pan, Jie, Bian, Yuan, Cao, Zhuo, Lei, Limei, Pan, Jiongwei, Huang, Jinwei, Cai, Xiaoping, Lan, Xiang, Zheng, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997019/ https://www.ncbi.nlm.nih.gov/pubmed/31846184 http://dx.doi.org/10.1111/1759-7714.13265 |
Ejemplares similares
-
Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer
por: Weber, Daniel Gilbert, et al.
Publicado: (2013) -
miR-138 suppresses the proliferation, metastasis and autophagy of non-small cell lung cancer by targeting Sirt1
por: Ye, Zaiting, et al.
Publicado: (2017) -
Pemetrexed-based first-line chemotherapy had particularly prominent objective response rate for advanced NSCLC: A network meta-analysis
por: Lv, Yuankai, et al.
Publicado: (2021) -
Construction and Validation of Early Warning Model of Lung Cancer Based on Machine Learning: A Retrospective Study
por: Ye, Siyu, et al.
Publicado: (2022) -
Dendritic cells infected with recombinant adenoviral vector encoding mouse fibroblast activation protein‐α and human livin α exert an antitumor effect against Lewis lung carcinoma in mice
por: Ye, Zaiting, et al.
Publicado: (2023)